Switching chemotherapy does not improve survival in metastatic breast cancer patients

[News]

For women with metastatic breast cancer who had elevated amounts of circulating tumor cells (CTCs) in their blood after a first line of chemotherapy, switching immediately to a different chemotherapy did not improve overall survival or time to progression, according to the results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

More... (http://www.news-medical.net/news/20131216/Switching-chemotherapy-does-not-improve-survival-in-metastatic-breast-cancer-patients-with-CTCs.aspx)